From February 10, 2022 to May 9, 2022, the company has repurchased 50,935 shares, representing 3.32% for KRW 4,220.26 million. With this, the company has completed the repurchase of 50,935 shares, representing 3.32% for KRW 4,220.26 million under the buyback announced on February 9, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19,600 KRW | 0.00% | -0.96% | -17.12% |
1st Jan change | Capi. | |
---|---|---|
-17.12% | 101M | |
+21.59% | 44.15B | |
+23.03% | 23.02B | |
+18.22% | 15.33B | |
+12.26% | 13.74B | |
+52.55% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.66B |
- Stock Market
- Equities
- A003120 Stock
- News Ilsung Is Co., Ltd.
- Tranche Update on Ilsung Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on February 9, 2022.